Rapport annuel d'activite ' -centre National de re 'fe 'rence Mycoses Invasives et Antifongiques, Institut Pasteur, 2016. ,
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline, Clin Microbiol Infect, vol.24, pp.1-38, 2018.,
URL : https://hal.archives-ouvertes.fr/hal-01953645
ESCMID Guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients, Clin Microbiol Infect, vol.18, pp.19-37, 2012. ,
, Reference method for broth dilution antifungal susceptibility testing of yeasts. Fourth informational sup-plement M27-S4, 2012.
Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp, Drug Resist Updat, vol.16, pp.81-95, 2013. ,
, European Committee on Antimicrobial Susceptibility Testing EUCAST. Anti-fungal_breakpoints_v_9.0_180212. EUCAST, 2018.
Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values, Clin Microbiol Infect, vol.12, pp.418-443, 2006. ,
Establishment and use of epide-miological cutoff values for molds and yeasts by use of the Clinical and Lab-oratory Standards Institute M57 Standard, J Clin Microbiol, vol.55, pp.1262-1270, 2017. ,
The role of epidemiological cutoff values (ECVs/ ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds, Rev Iberoam Micol, vol.33, pp.63-75, 2016. ,
Posaconazole MIC distributions for Aspergillus fumi-gatus species complex by four methods: impact of cyp51A mutations on estimation of epidemiological cutoff values, Antimicrob Agents Chemother, vol.62, pp.1916-1923, 2018. ,
Method-dependent epidemiological cutoff values (ECVs) for detection of triazole resistance in Candida and Aspergillus species for the SYO colorimetric broth and Etest agar diffusion methods, Antimicrob Agents Chemother, vol.63, pp.1651-1669, 2018. ,
Multilaboratory study of epidemiological cutoff values for detection of species to fluconazole, posaconazole, and vor-iconazole, Antimicrob Agents Chemother, vol.58, 2014. ,
Multicenter study of method-dependent epidemiological cutoff values for detection of resistance in Candida spp. and Aspergillus spp. to Amphotericin B and echinocandins for the Etest agar diffusion method, Anti-microb Agents Chemother, vol.61, pp.1792-1808, 2016. ,
In vitro antifungal suscep-tibility testing of Candida isolates with the EUCAST methodology, a new method for ECOFF determination, Antimicrob Agents Chemother, vol.61, pp.2372-2388, 2017. ,
Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, J Clin Microbiol, vol.50, pp.2846-56, 2010. ,
Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method, Antimicrob Agents Chemother, vol.58, pp.916-938, 2014. ,
, Epidemiological cutoff values for antifungal susceptibility testing M59, 2016.
Wildtype MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document), Antimicrob Agents Chemother, vol.55, pp.2855-2864, 2011. ,
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution, J Clin Microbiol, vol.50, pp.2040-2046, 2012. ,
Etest antifungal susceptibility testing for in vitro diagnostic use package insert. Marcy l'E ' toile: bioMe 'rieux, 2013. ,
Summary of etest. Performance interpretative criteria and quality control ranges. Marcy l'E ' toile: bioMe 'rieux, 2018. ,
Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method, Antimicrob Agents Chemother, vol.57, pp.5426-5457, 2013. ,
, European Committee on Antimicrobial Susceptibility Testing EUCAST. EUCAST Antimicrobial wild type distributions of microorganisms, 2018.
Antifungal sus-ceptibility testing results of New Zealand yeast isolates, 2001e2015: impact of recent CLSI breakpoints and epidemiological cut-off values for Candida and other yeast species, J Glob Antimicrob Resist, vol.14, pp.72-79, 2018. ,
Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and inter-pretive criteria, J Clin Microbiol, vol.52, pp.3223-3232, 2014. ,
Comparative evaluation of etest and Sensititre YeastOne panels against the clinical and laboratory standards Institute M27-A2 reference broth micro-dilution method for testing Candida susceptibility to seven antifungal agents, J Clin Microbiol, vol.45, pp.698-706, 2007. ,
Evaluation of antifungal susceptibility testing with microdilution and Etest methods of Candida blood isolates, Mycopathologia, vol.172, pp.187-99, 2011. ,
Antifungal sus-ceptibility profile of cryptic species of Aspergillus, Mycopathologia, vol.178, pp.427-460, 2014. ,
Lass-Flo ?rl C. Etest and Sensititre Yea-stOne susceptibility testing of echinocandins against Candida species from a single center in Austria, Antimicrob Agents Chemother, vol.61, pp.512-519, 2017. ,
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories, Clin Microbiol Infect, vol.16, pp.863-872, 2010. ,